未登录
分享
收藏TAS3351, a fourth-generation brain-penetrating EGFR inhibitor designed to target common EGFR mutations, including those with or without T790M and C797S resistance mutations
Iwasaki, J.; Kasuga, H.; Kataoka, Y.; Muraoka, H.; Yamamoto, F.; Tsuji, S.; Tanaka, S.; Hashimoto, A.; Miyamoto, R.; Mizuarai, S.; Ohkubo, S.
分享
收藏
分享
收藏HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis
Takahashi, Satoshi; Kanai, Akinori; Okuda, Hiroshi; Miyamoto, Ryo; Komata, Yosuke; Kawamura, Takeshi; Matsui, Hirotaka; Inaba, Toshiya; Takaori-Kondo, Akifumi; Yokoyama, Akihiko
分享
收藏Activation of CpG-Rich Promoters Mediated by MLL Drives MOZ-Rearranged Leukemia
Miyamoto, Ryo; Okuda, Hiroshi; Kanai, Akinori; Takahashi, Satoshi; Kawamura, Takeshi; Matsui, Hirotaka; Kitamura, Toshio; Kitabayashi, Issay; Inaba, Toshiya; Yokoyama, Akihiko
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏